Expert Perspectives: Management of Acute Myeloid Leukemia

Expert Perspectives: Management of Acute Myeloid Leukemia

Episodes

Specialty:

All

Year:

All

EP. 1: Pathobiology of Acute Myeloid Leukemias (AML)

January 7th 2016

EP. 2: Development of Secondary Acute Myeloid Leukemias

January 7th 2016

EP. 3: Risk Stratification of Myelodysplastic Syndromes and AML

January 7th 2016

EP. 4: Prognostic Factors in Acute Myeloid Leukemia

January 7th 2016

EP. 5: Prognostic Factors in Acute Myeloid Leukemia Treatment

January 7th 2016

EP. 6: Evolution in Acute Myeloid Leukemia Induction Strategies

January 7th 2016

EP. 7: Consolidation Strategies in AML Treatment

January 7th 2016

EP. 8: Management of Primary Refractory AML

January 7th 2016

EP. 9: Emerging Therapeutic Approaches in AML

January 7th 2016

EP. 10: Immunotherapy in Acute Myeloid Leukemia

January 7th 2016

EP. 11: The Importance of Supportive Care in AML

January 7th 2016

EP. 12: Infection Prophylaxis in Acute Myeloid Leukemia

January 7th 2016

EP. 13: Multidisciplinary Team in Acute Myeloid Leukemia

January 7th 2016

Trending on OncLive

FDA Grants Fast Track Designation to Pan-RAS Molecular Glue ERAS-0015 for Metastatic Pancreatic Adenocarcinoma

Darlifarnib Plus Cabozantinib Displays Early Signals of Safety and Efficacy in RCC

The OncFive: Top Oncology Articles for the Week of 8/16

Five Under 5: Top Oncology Videos for the Week of 8/16

FDA Grants Priority Review to Dostarlimab for dMMR/MSI-H Locally Advanced Rectal Cancer